|
|
A组(） |
B组(） |
C组(） |
|
|
| 并发症 |
4 (10%) |
2 (5%) |
4 (15%) |
≤0.01 |
| 主要 |
2 (5%) |
1 (2.5%) |
2 (7%) |
≤0.01 |
| 小 |
2 (5%) |
1 (2.5%) |
2 (7%) |
≤0.01 |
| 复发和病因 |
10 (26%) |
3 (8%) |
3 (11%) |
≤0.01 |
| 肺结核 |
6 (16%) |
0 |
0 |
≤0.01 |
| 恶性肿瘤 |
3 (8%) |
0 |
0 |
≤0.01 |
| İdiopathic |
1 (2%) |
3 (8%) |
3 (11%) |
≤0.01 |
| 30天死亡率 |
2 (5%) |
1 (3%) |
2 (8%) |
≤0.01 |
| 出口 |
5 (13%) |
3 (8%) |
4 (15%) |
≤0.01 |
| 凝血障碍 |
1 (2.6%) |
0 |
1 (4%) |
≤0.01 |
| 缺血性心脏病和心力衰竭 |
1 (2.6%) |
0 |
0 |
≤0.01 |
| 肺结核 |
1 (2.6%) |
0 |
0 |
≤0.01 |
| 恶性肿瘤 |
2 (5%) |
3 (8%) |
3 (11%) |
≤0.01 |
| 完整的跟踪 |
36 (94%) |
34 (94%) |
24 (92%) |
NS |
|
|
